Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Blood Purif ; 47(1-3): 270-276, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30522094

RESUMO

BACKGROUND: Sepsis is a life-threatening condition often associated with a high incidence of multiple organs injury. Several papers suggested the immune response by itself, with the production of humoral inflammatory mediators, is crucial in determining organ injury. However, little is known of how sepsis directly induces organ injury at the cellular levels. To assess this point, we set up an in vitro study to investigate the response of renal tubular cells (RTCs), monocytes (U937) and hepatocytes (HepG2) after 24 h-incubation with septic patients' plasma. METHODS: We enrolled 26 septic patients ("test" group). We evaluated cell viability, apoptosis and necrosis by flow cytometer. Caspase-3,-8,-9 and cytochrome-c concentrations have been analyzed using the Human enzyme-linked immunosorbent assay kit. RESULTS: We found that a decrease of cell viability in all cell lines tested was associated to the increase of apoptosis in RTCs and U937 (p < 0.0001) and increase of necrosis in HepG2 (p < 0.5). The increase of apoptosis in RTCs and U937 cells was confirmed by higher levels of caspase-3 (p < 0.0001). We showed that apoptosis in both RTCs and U937 was triggered by the activation of the intrinsic pathway, as caspase-9 and cytochrome-c levels significantly increased (p < 0.0001), while caspase-8 did not change. This assumption was strengthened by the significant correlation of caspase-9 with both cytochrome-c (r = 0.73 for RTCs and r = 0.69 for U937) and caspase-3 (r = 0.69 for RTCs and r = 0.63 for U937). CONCLUSION: Humoral mediators in septic patients' plasma induce apoptosis. This fact suggests that apoptosis inhibitors should be investigated as future strategy to reduce sepsis-induced organ damages.


Assuntos
Apoptose , Hepatócitos/metabolismo , Túbulos Renais Proximais/metabolismo , Monócitos/metabolismo , Plasma , Sepse/sangue , Caspases/metabolismo , Sobrevivência Celular , Citocromos c/metabolismo , Células Hep G2 , Hepatócitos/patologia , Humanos , Túbulos Renais Proximais/patologia , Monócitos/patologia , Células U937
2.
Anal Cell Pathol (Amst) ; 2015: 469461, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26266085

RESUMO

Background. Cardiorenal Syndrome Type 5 (CRS Type 5) reflects concomitant cardiac and renal dysfunctions in the setting of a wide spectrum of systemic disorders. Our aim was to study in vitro effects of CRS Type 5 plasma on renal tubular cells (RTCs), in terms of cellular death and the characterization of inflammatory plasma profile in these patients. Material and Methods. We enrolled 11 CRS Type 5 patients from ICU and 16 healthy controls. Plasma from patients and controls was incubated with renal tubular cells (RTCs) and cell death was evaluated. Plasma cytokines were detected. Results. RTCs incubated with CRS Type 5 plasma showed significantly higher apoptosis and necrosis with respect to controls. Plasma cytokine profile of CRS Type 5 patients was significantly different from controls: we observed the production of pro- and anti-inflammatory mediators in these patients. Caspase-3, caspase-8, and caspase-9 were activated in cells treated with CRS Type 5 plasma compared to controls. Conclusions. Our results underline the cytotoxic effect of CRS Type 5 mediators on RTC viability, probably due to the activation of both intrinsic and extrinsic pathways of apoptosis and to the deregulation of cytokine release. The consequence may be the damage of distant organs which lead to the worsening of condition of patients.


Assuntos
Síndrome Cardiorrenal/complicações , Síndrome Cardiorrenal/patologia , Inflamação/complicações , Inflamação/patologia , Túbulos Renais/patologia , Proteínas de Fase Aguda , Idoso , Apoptose , Síndrome Cardiorrenal/sangue , Estudos de Casos e Controles , Caspases/metabolismo , Sobrevivência Celular , Feminino , Humanos , Inflamação/sangue , Lipocalina-2 , Lipocalinas/sangue , Masculino , Necrose , Proteínas Proto-Oncogênicas/sangue
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa